Similar Search Results

A ban on "private label" generic pharmaceuticals : legal and economic context

Anis, Aslam H.; Harvard, Stephanie - In: International journal of the economics of business 22 (2015) 2, pp. 219-229

Persistent link: https://www.econbiz.de/10011405945

How do drug prices respond to a change from external to internal reference pricing? : evidence from a Danish regulatory reform

Kaiser, Ulrich; Mendez, Susan J. - 2015 - This version: January 5, 2015

We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals … analyze three therapeutic classes with different treatment durations and show that the reform led to substantial price … decreases for our lifelong treatment and to less substantial price reductions for our medium duration treatment while we do not …

Persistent link: https://www.econbiz.de/10010462523

Reference pricing of pharmaceuticals for Medicare : evidence from Germany, the Netherlands, and New Zealand

Danzon, Patricia Munch; Ketcham, Jonathan D. - In: Frontiers in health policy research 7 (2004), pp. 1-54

Persistent link: https://www.econbiz.de/10002227583

Moving towards an improved microsimulation model of the Australian pharmaceutical benefits scheme

Brown, Laurie; Abello, Annie; Phillips, Ben; Harding, Ann - In: The Australian economic review 37 (2004) 1, pp. 41-61

Persistent link: https://www.econbiz.de/10002179846

Drug price control in India : an overview

Shah, Mansi B.; Patel, Amit S. - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 2, pp. 123-131

Persistent link: https://www.econbiz.de/10002185665

Drug pricing policy in Hungary

Vincze, Zoltán; Zelkó, Romána; Mészáros, Ágnes - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 3, pp. 189-204

Persistent link: https://www.econbiz.de/10002185669

Germany's attempts to control drug prices and expenditures : Success or failure?

Dietrich, Eva Susanne - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 3, pp. 205-234

Persistent link: https://www.econbiz.de/10002185670

The controls of price of medicines in Israel

Moshenson, Avi; Rice, Howard - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 3, pp. 261-267

Persistent link: https://www.econbiz.de/10002185673

Regulierung des Marktes für verschreibungspflichtige Arzneimittel im internationalen Vergleich ; [Tab.]

Greß, Stefan; Niebuhr, Dea; Wasem, Jürgen - 2005 - 1. Aufl.

Persistent link: https://www.econbiz.de/10002956512

Generic script share and the price of brand-name drugs : the role of consumer choice

Rizzo, John A.; Zeckhauser, Richard - 2005

Persistent link: https://www.econbiz.de/10002957519